Compare AOUT & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOUT | ARMP |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.9M | 156.4M |
| IPO Year | 2020 | 1996 |
| Metric | AOUT | ARMP |
|---|---|---|
| Price | $12.81 | $4.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $12.50 | ★ $15.00 |
| AVG Volume (30 Days) | 54.1K | ★ 146.9K |
| Earning Date | 03-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $190,536,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.26 | $2.40 |
| 52 Week High | $14.97 | $14.98 |
| Indicator | AOUT | ARMP |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 44.28 |
| Support Level | $12.24 | $4.36 |
| Resistance Level | $14.97 | $5.60 |
| Average True Range (ATR) | 0.50 | 0.50 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 36.25 | 34.01 |
American Outdoor Brands Inc is the provider of outdoor lifestyle products and shooting sports accessories encompassing hunting, fishing, meat processing, outdoor cooking, shooting, and personal security and defense products for rugged outdoor enthusiasts. It conceive, design, produce or source, and sell its outdoor lifestyle products including premium sportsman knives, land management tools, products used while hunting, meat processing equipment; and outdoor cooking products and hooting sports accessories, including rests, vaults, and other related accessories, electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips, etc. The company operate as one reporting segment.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.